
open3 visninger
Canada
The Prix Galien Canada – Product Innovation Award
An annual award presented to a company that has developed a drug product launched on the Canadian market, judged by the jury to have made the most significant overall contribution to patient care in Canada in terms of efficacy, safety, benefits, and innovation.
Hvem kan ansøge
Companies with a drug launched in Canada at least 12 months and no more than 60 months (5 years) ago, considered a 'break-through' rather than a derivative, with major impact on standards of care. The drug must meet the definition of 'drug' under the Food and Drug Act.Nøglekontakter
Wilma Deen
Kilder
Links brugt af AI til at indsamle information om dette legat.
- hrf-frs.com/awards/the-prix-galien-canada-product-innovation-award/ ↗
- hrf-frs.com/ ↗
- innovativemedicines.ca/wp-content/uploads/2024/04/2024_Prix_Galien_Product_Award… ↗
- research.ucalgary.ca/opportunity/2025-prix-galien-canada-product-innovation-awar… ↗
- hrf-frs.com/wp-content/uploads/sites/2/2026/03/2026_Prix_Galien_Product_Award_Gu… ↗
- [email protected] ↗
- research.ucalgary.ca/opportunity/2026-health-research-foundation-medal-honour ↗
- innovativemedicines.ca/contact/sponsorship-applications/ ↗
